Skip to main content
. Author manuscript; available in PMC: 2024 Jan 29.
Published in final edited form as: J Neurosurg Pediatr. 2022 Jul 29;30(4):428–436. doi: 10.3171/2022.6.PEDS22177

TABLE 2.

Postshunt ETV procedure summary

Overall,
n = 203
Age at time of ETV in yrs, median (IQR) 4.1 (1.0–10.2)
FOR, median (IQR)* 0.48 (0.42–0.58)
Septostomy performed 23 (17.3%)
CPC done
 None 106 (67.1%)
 Unilat— partial 7 (4.4%)
 Unilat— complete 4 (2.5%)
 Bilat— partial 13 (8.2%)
 Bilat— complete 28 (17.7%)
Bleeding during procedure
 None 117 (57.6%)
 Mild 75 (36.9%)
 Moderate 9 (4.4%)
 Severe 2 (1.0%)
Dilation method§
 Forceps 28 (15.6%)
 Fogarty catheter 51 (28.3%)
 Neuroballoon 46 (25.6%)
 Spreader 8 (4.4%)
 Endoscope 32 (17.8%)
 Multiple 15 (8.3%)
BA clear view 170 (92.9%)
EVD placement during ETV procedure** 107 (57.5%)
Length of stay after ETV in days, median (IQR)†† 5.0 (2.0–10.0)
ETV was part of a shunt infection treatment 50 (24.6%)
*

Missing in 31 patients.

Missing in 70 patients.

Missing in 45 patients.

§

Missing in 23 patients.

Missing in 20 patients.

**

Missing in 17 patients.

††

Missing in 4 patients.